Starling Oncology, Inc. (STLN)
6.17
-0.03
(-0.48%)
USD |
NASDAQ |
Sep 11, 16:00
6.19
+0.02
(+0.32%)
After-Hours: 20:00
Starling Oncology Enterprise Value : 683.28M for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 683.28M |
| September 10, 2026 | 686.29M |
| September 09, 2026 | 695.33M |
| September 08, 2026 | 698.35M |
| September 04, 2026 | 659.16M |
| September 03, 2026 | 663.18M |
| September 02, 2026 | 675.24M |
| September 01, 2026 | 660.17M |
| August 31, 2026 | 657.15M |
| August 28, 2026 | 683.28M |
| August 27, 2026 | 700.36M |
| August 26, 2026 | 722.46M |
| August 25, 2026 | 696.34M |
| August 24, 2026 | 679.26M |
| August 21, 2026 | 712.91M |
| August 20, 2026 | 720.45M |
| August 19, 2026 | 732.51M |
| August 18, 2026 | 706.38M |
| August 17, 2026 | 697.34M |
| August 14, 2026 | 711.41M |
| August 13, 2026 | 692.32M |
| August 12, 2026 | 698.35M |
| August 11, 2026 | 685.79M |
| August 10, 2026 | 682.27M |
| August 07, 2026 | 707.39M |
| Date | Value |
|---|---|
| August 06, 2026 | 564.72M |
| August 05, 2026 | 568.74M |
| August 04, 2026 | 582.81M |
| August 03, 2026 | 578.79M |
| July 31, 2026 | 551.66M |
| July 30, 2026 | 572.76M |
| July 29, 2026 | 542.62M |
| July 28, 2026 | 560.70M |
| July 27, 2026 | 584.82M |
| July 24, 2026 | 563.72M |
| July 23, 2026 | 572.76M |
| July 22, 2026 | 594.86M |
| July 21, 2026 | 608.93M |
| July 20, 2026 | 615.96M |
| July 17, 2026 | 600.89M |
| July 16, 2026 | 591.85M |
| July 15, 2026 | 632.04M |
| July 14, 2026 | 694.33M |
| July 13, 2026 | 691.31M |
| July 10, 2026 | 655.14M |
| July 09, 2026 | 651.13M |
| July 08, 2026 | 631.03M |
| July 07, 2026 | 646.10M |
| July 06, 2026 | 609.93M |
| July 02, 2026 | 593.86M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Astrana Health, Inc. | 2.215B |
| Agilon Health, Inc. | 1.283B |
| Nakamoto, Inc. | 292.19M |
| American Oncology Network, Inc. | -- |
| Sonida Senior Living, Inc. | 3.379B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.241M |
| Revenue (Quarterly) | 161.28M |
| Total Expenses (Quarterly) | 169.52M |
| EPS Diluted (Quarterly) | -0.08 |
| Gross Profit Margin (Quarterly) | 15.70% |
| Profit Margin (Quarterly) | -5.11% |
| Earnings Yield | -4.95% |
| Normalized Earnings Yield | -4.570 |